New patent expiration for Valeant Pharms drug CARAC

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for CARAC
Annual Drug Patent Expirations for CARAC

Carac is a drug marketed by Valeant Pharms North and is included in one NDA. It is available from three suppliers. There is one patent protecting this drug and one Paragraph IV challenge.

CARAC drug price trends.

Drug patent litigation for CARAC.

The generic ingredient in CARAC is fluorouracil. Three suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top